Article

Corneal collagen cross-linking halts keratoconus progression

Anaheim, CA-Cross-linking of corneal collagen by topical treatment with riboflavin and ultraviolet (UV) light exposure shows promise as a safe, effective, simple, and inexpensive nonsurgical treatment for keratoconus, said Theo Seiler, MD, PhD, at the annual meeting of the American Academy of Ophthalmology.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
© 2024 MJH Life Sciences

All rights reserved.